Boundless Bio Stock Quote BOLD - Stock Price, News, Charts, Message Board, Trades

Professional-Grade Tools, for Individual Investors.

Premium

Current Price

11.015

Bid

10.95

Ask

11.04

Volume

40,196

10.71 Day's Range 11.25

8.51 52 Week Range 15.20

Market Cap

3.452B

Previous Close

11.02

Open

10.71

Last Trade

11.04

Last Trade Time

13:06:48

Financial Volume

$ 442,519

VWAP

11.009

Average Volume (3m)

169,694

Shares Outstanding

311,794,000

Dividend Yield

PE Ratio

-69.84

Earnings Per Share (EPS)

-0.16

Revenue

Net Profit

-49.43M

Boundless Bio, Inc., a clinical-stage oncology company, develops cancer therapeutics to address the unmet need of patients with oncogene amplified tumors by targeting extrachromosomal DNA. Its lead product candidate is BBI-355, an oral inhibitor of checkpoint kinase 1 that is in Phase 1/2 clinical t... Boundless Bio, Inc., a clinical-stage oncology company, develops cancer therapeutics to address the unmet need of patients with oncogene amplified tumors by targeting extrachromosomal DNA. Its lead product candidate is BBI-355, an oral inhibitor of checkpoint kinase 1 that is in Phase 1/2 clinical trial in patients with oncogene amplified cancers. The company is also developing BBI-825, an oral inhibitor of ribonucleotide reductase, which is in Phase 1/2 clinical trial in cancer patients with resistance gene amplifications; and ecDTx 3 program targeting a kinesin involved with the cellular mechanism for segregation of ecDNA. Boundless Bio, Inc. was formerly known as Pretzel Therapeutics, Inc. and changed its name to Boundless Bio, Inc. in July 2019. The company was incorporated in 2018 and is headquartered in San Diego, California. Show more

Sector

Pharmaceutical Preparations

Industry

Pharmaceutical Preparations

Website

www.boundlessbio.com

Headquarters

Wilmington, Delaware, USA

Founded

1970

Boundless Bio Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker BOLD. The last closing price for Boundless Bio was $11.02. Over the last year, Boundless Bio shares have traded in a share price range of $ 8.51 to $ 15.20.

Boundless Bio currently has 311,794,000 shares outstanding. The market capitalization of Boundless Bio is $3.45 billion. Boundless Bio has a price to earnings ratio (PE ratio) of -69.84.

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Form 8-K - Current report

Boundless Bio Reports First Quarter 2024 Financial Results and Corporate Highlights

BBI-355 Phase 1/2 POTENTIATE clinical trial ongoing; initiated targeted therapy combinations in patients with tumors with EGFR or FGFR oncogene amplifications First patient dosed in Phase 1/2...

Boundless Bio to Present at the Citizens JMP Life Sciences Conference 2024

Boundless Bio (Nasdaq: BOLD), a clinical-stage oncology company interrogating extrachromosomal DNA (ecDNA) biology to deliver transformative therapies to patients with previously intractable...

Boundless Bio Announces First Patient Dosed in First-in-Human Phase 1/2 Clinical Trial of BBI-825 in Cancer Patients with Resistance Gene Amplifications

STARMAP (Study Treating Acquired Resistance: MAPK Amplifications) is a first-in-human, 3-part, Phase 1/2 study of BBI-825 as a single agent and in combination with select targeted cancer...

Boundless Bio Presents Preclinical and Clinical Pharmacodynamic Data on its Lead Extrachromosomal DNA (ecDNA)-Directed Therapy, BBI-355, at the American Association for Cancer Research Annual Meeting 2024

Findings support the ongoing development of BBI-355, a novel, oral, selective inhibitor of checkpoint kinase 1 (CHK1) in Phase 1/2 development, as a differentiated treatment approach for...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	1.875	20.5142231947	9.14	11.9036	8.945	102269	10.49501482	CS
4	0.215	1.99074074074	10.8	12.6484	8.51	98000	10.15700818	CS
12	-3.235	-22.701754386	14.25	15.2	8.51	169694	11.86608013	CS
26	-3.235	-22.701754386	14.25	15.2	8.51	169694	11.86608013	CS
52	-3.235	-22.701754386	14.25	15.2	8.51	169694	11.86608013	CS
156	-3.235	-22.701754386	14.25	15.2	8.51	169694	11.86608013	CS
260	-26.015	-70.2538482312	37.03	60	8.51	639841	45.99808601	CS

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
ONMDOneMedNet Corporation	$ 1.17 (138.78%)	151.69M
ASTIAscent Solar Technologies Inc	$ 0.219 (66.67%)	601.88M
BCGBinah Capital Group Inc	$ 6.55 (55.21%)	12.59M
RENBRenovaro Inc	$ 1.39 (47.87%)	3.64M
ZCARZoomcar Holdings Inc	$ 0.3031 (44.33%)	102.24M
SWINSolowin Holdings	$ 4.03 (-89.78%)	9.53M
TOIIWOncology Institute Inc	$ 0.0502 (-49.70%)	2
GVVisionary Holdings Inc	$ 0.22 (-42.21%)	1.12M
MGOLMGO Global Inc	$ 0.722 (-37.76%)	6.77M
AKTSAkoustis Technologies Inc	$ 0.2226 (-29.36%)	32.41M
GWAVGreenwave Technology Solutions Inc	$ 0.0999 (26.78%)	1.02B
ASTIAscent Solar Technologies Inc	$ 0.219 (66.67%)	601.88M
PEGYPineapple Energy Inc	$ 0.205801 (37.29%)	349.67M
FFIEFaraday Future Intelligent Electric Inc	$ 1.215 (8.48%)	166.84M
ONMDOneMedNet Corporation	$ 1.17 (138.78%)	151.69M